Download PDF
Klin Monbl Augenheilkd 2009; 226(8): e1-e15
DOI: 10.1055/s-0029-1185822
KliMo-Refresher
Rubrikherausgeber: G. Duncker, Halle
© Georg Thieme Verlag KG Stuttgart · New York

Retinologische Notfälle

J. Hillenkamp1 , J. Roider1 , B. Nölle1 , H. Hoerauf2 , L.-O. Hattenbach3
  • 1Klinik für Ophthalmologie, Universitätsklinikum Schleswig Holstein, Campus Kiel
  • 2Augenklinik der Universitätsmedizin Göttingen
  • 3Augenklinik des Klinikums Ludwigshafen
Further Information

Publication History

Publication Date:
11 August 2009 (online)

Also available at
    Permissions and Reprints

Einleitung

Bei verschiedenen Netzhauterkrankungen bestimmt das schnelle und adäquate Handeln des Erstuntersuchers die Prognose erheblich. Ein möglichst reibungsloses und gutes Zusammenspiel zwischen den Beteiligten der Behandlungskette ist erforderlich. Das korrekte und zeitgerechte Management verschiedener typischer retinologischer Notfallsituationen soll daher Thema dieses Fortbildungsartikels sein. Dabei haben wir uns auf 2 häufige und eine seltenere, aber umso dringlichere retinale Erkrankung fokussiert: die akute retinale Nekrose, die rhegmatogene Ablatio und die retinalen Gefäßverschlüsse. Antworten auf die folgenden Fragen sollen dem Leser vermittelt werden:

Woran erkenne ich eine akute retinale Nekrose? Wann ist eine Ablatio ein Notfall? Welcher Gefäßverschluss ist dringlich?

Literatur

  • 1 Urayama A, Yamada N, Sasaki T. Unilateral acute uveitis with retinal periarteritis and detachment.  Rinsho Ganka. 1971;  25 607-619
    PubMedGoogle Scholar
  • 2 Young N J, Bird A C. Bilateral acute retinal necrosis.  Br J Ophthalmol. 1978;  62 581-590
    PubMedGoogle Scholar
  • 3 Culbertson W W, Blumenkranz M S, Haines H et al. The acute retinal necrosis syndrome. Part 2: histopathology and etiology.  Ophthalmology. 1982;  89 1317-1325
    PubMedGoogle Scholar
  • 4 Culbertson W W, Blumenkranz M S, Pepose J S et al. Varicella zoster virus is a cause of the acute retinal necrosis syndrome.  Ophthalmology. 1986;  93 559-569
    PubMedGoogle Scholar
  • 5 Lewis M L, Culbertson W W, Post J D et al. Herpes simplex virus type 1: a cause of the acute retinal necrosis syndrome.  Ophthalmology. 1989;  96 875-878
    PubMedGoogle Scholar
  • 6 Lau C H, Missotten T, Salzmann J et al. Acute retinal necrosis. Features, management, and outcomes.  Ophthalmology. 2007;  114 756-762
    CrossrefPubMedGoogle Scholar
  • 7 Hillenkamp J, Nölle B, Bruns C et al. Acute retinal necrosis: clinical features, early vitrectomy, and outcomes.  Ophthalmology. DOI: 10.1016/j.ophtha.2009.03.029
    PubMedGoogle Scholar
  • 8 Chodosh J, Gan Y J, Sixbey J W. Detection of Epstein-Barr virus genome in ocular tissue.  Ophthalmology. 1996;  103 687-690
    PubMedGoogle Scholar
  • 9 Holland G N. Executive Committee of the American Uveitis Society . Standard diagnostic criteria for the acute retinal necrosis syndrome.  Am J Ophthalmol. 1994;  117 663-667
    PubMedGoogle Scholar
  • 10 Matsuo T, Nakayama T, Koyama T et al. A proposed mild type of acute retinal necrosis.  Am J Ophthalmol. 1988;  105 579-583
    PubMedGoogle Scholar
  • 11 Matsuo T, Morimoto K, Matsuo N. Factors associated with poor visual outcome in acute retinal necrosis.  Br J Ophthalmol. 1991;  75 450-454
    PubMedGoogle Scholar
  • 12 Holland G N, Cornell P J, Park M S et al. An association between acute retinal necrosis syndrome and HLA-DQw7 and phenotype Bw62, DR4.  Am J Ophthalmol. 1989;  108 370-374
    PubMedGoogle Scholar
  • 13 Matsuo T, Matsuo N. HLA-DR9 associated with the severity of acute retinal necrosis syndrome.  Ophthalmologica. 1991;  203 133-137
    PubMedGoogle Scholar
  • 14 Labetoulle M, Kucera P, Ugolini G et al. Neuronal pathways for the propagation of herpes simplex virus type 1 from one retina to the other in a murine model.  J Gen Virol. 2000;  81 1201-1210
    PubMedGoogle Scholar
  • 15 Muthiah M N, Michaelides M, Child C S et al. Acute retinal necrosis: a national population-based study to assess the incidence, methods of diagnosis, treatment strategies and outcomes in the UK.  Br J Ophthalmol. 2007;  91 1452-1455
    CrossrefPubMedGoogle Scholar
  • 16 Luu K K, Scott I U, Chaudhry N A et al. Intravitreal antiviral injections as adjunctive therapy in the management of immunocompetent patients with necrotizing herpetic retinopathy.  Am J Ophthalmol. 2000;  129 811-813
    CrossrefPubMedGoogle Scholar
  • 17 Scott I U, Luu K M, Davis J L. Intravitreal antivirals in the management of patients with acquired immunodeficiency syndrome with progressive outer retinal necrosis.  Arch Ophthalmol. 2002;  120 1219-1222
    PubMedGoogle Scholar
  • 18 Emerson G G, Smith J R, Wilson D J et al. Primary treatment of acute retinal necrosis with oral antiviral therapy.  Ophthalmology. 2006;  113 2259-2261
    CrossrefPubMedGoogle Scholar
  • 19 Aizman A, Johnson M W, Elner S G. Treatment of acute retinal necrosis syndrome with oral antiviral medications.  Ophthalmology. 2007;  114 3-12
    CrossrefPubMedGoogle Scholar
  • 20 Ando F, Kato M, Goto S et al. Platelet function in bilateral acute retinal necrosis.  Am J Ophthalmol. 1983;  96 27-32
    PubMedGoogle Scholar
  • 21 Han D P, Lewis H, Williams G A et al. Laser photocoagulation in the acute retinal necrosis syndrome.  Arch Ophthalmol. 1987;  105 1051-1054
    PubMedGoogle Scholar
  • 22 Sternberg Jr. P, Han D P, Yeo J H et al. Photocoagulation to prevent retinal detachment in acute retinal necrosis.  Ophthalmology. 1988;  95 1389-1393
    PubMedGoogle Scholar
  • 23 Crapotta J A, Freeman W R, Feldman R M et al. Visual outcome in acute retinal necrosis.  Retina. 1993;  13 208-213
    CrossrefPubMedGoogle Scholar
  • 24 Hudde T, Althaus C, Sundmacher R. Acute retinal necrosis syndrome: argon laser coagulation for prevention of rhegmatogenic retinal detachment (in German).  Ophthalmologe. 1998;  95 473-477
    CrossrefPubMedGoogle Scholar
  • 25 McDonald H R, Lewis H, Kreiger A E et al. Surgical management of retinal detachment associated with the acute retinal necrosis syndrome.  Br J Ophthalmol. 1991;  75 455-458
    PubMedGoogle Scholar
  • 26 Park J J, Pavesio C. Prophylactic laser photocoagulation for acute retinal necrosis. Does it raise more questions than answers?.  Br J Ophthalmol. 2008;  92 2
    PubMedGoogle Scholar
  • 27 Phan D D, Chin-Hong P, Lin E T et al. Intra- and interindividual variabilities of valaciclovir oral bioavailability and effect of coadministration of an hPEPT1 inhibitor.  Antimicrob Agents Chemother. 2003;  47 2351-2353
    CrossrefPubMedGoogle Scholar
  • 28 Norton E W D. Retinal detachment in aphakia.  Trans Am Ophthalmol Soc. 1963;  61 770-789
    PubMedGoogle Scholar
  • 29 Lincoff H. Guilty until proven innocent.  Arch Ophthalmol. 1967;  78 271
    PubMedGoogle Scholar
  • 30 Burton T C. Recovery of visual acuity after retinal detachment involving the macula.  Trans Am Ophthalmol Soc. 1982;  80 475-497
    PubMedGoogle Scholar
  • 31 Kreissig I, Lincoff H. Die unaufschiebbare Ablatiooperation.  Klin Mbl Augenheilkd. 1974;  165 315-318
    PubMedGoogle Scholar
  • 32 Kreissig I. Weitere klinische Erfahrungen über die unaufschiebbare Ablatio-Operation.  Klin Mbl Augenheilkd. 1977;  171 530-538
    PubMedGoogle Scholar
  • 33 Kreissig I. Prognosis of return of macular function after retinal reattachment.  Mod Probl Ophthalmol. 1977;  18 415
    PubMedGoogle Scholar
  • 34 Gundry M F, Davies E W G. Recovery of visual acuity after retinal detachment surgery.  Am J Ophthalmol. 1974;  77 310
    PubMedGoogle Scholar
  • 35 Frimpong-Ansah K, Kirkby G R. Arrangements for the management of urgent retinal detachments in the United Kingdom and Eire in the year 2000: Results of a survey.  Eye. 2002;  16 754-760
    CrossrefPubMedGoogle Scholar
  • 36 Hartz A J, Burton T C, Gottlieb M A et al. Outcome and cost analysis of scheduled versus emergency scleral buckling surgery.  Ophthalmology. 1992;  99 1358-1363
    PubMedGoogle Scholar
  • 37 Cohen S M. Natural history of asymptomatic clinical retinal detachments.  Am J Ophthalmol. 2005;  139 777-779
    CrossrefPubMedGoogle Scholar
  • 38 Davis M D. The natural history of retinal breaks without detachment.  Arch Ophthalmol. 1974;  92 183-194
    PubMedGoogle Scholar
  • 39 Byer N E. Subclinical retinal detachment resulting from asymptomatic retinal breaks: prognosis for progression and regression.  Ophthalmology. 2001;  108 1499-1503
    CrossrefPubMedGoogle Scholar
  • 40 Ross W H, Kozy D W. Visual recovery in macula-off rhegmatogenous retinal detachments.  Ophthalmology. 1998;  105 2149-2153
    CrossrefPubMedGoogle Scholar
  • 41 Ross W H. Visual recovery after macula-off retinal detachment.  Eye. 2002;  14 440-446
    PubMedGoogle Scholar
  • 42 La Cour M. Persönliche Mitteilung. 
    Google Scholar
  • 43 Mowatt L, Shun-Shin G A, Arora S et al. Macula off retinal detachments. How long can we wait before it is too late?.  Eur J Ophthalmol. 2005;  15 109-117
    PubMedGoogle Scholar
  • 44 Winkler J, Hoerauf H. The retinal organ culture – a model system for the examination of the early cytoskeletal reaction pattern after retinal detachment.  Klin Mbl Augenheilkd. 2008;  225 269-275
    PubMedGoogle Scholar
  • 45 Ross W, Lavina A, Russell M et al. The correlation between height of macular detachment and visual outcome in macula-off retinal detachments of < 7 days' duration.  Ophthalmology. 2005;  112 1213-1217
    CrossrefPubMedGoogle Scholar
  • 46 Tani P, Robertson D M, Langwothy A. Rhegmatogenous retinal detachment without macular involvement treated with scleral buckling.  Am J Ophthalmol. 1980;  90 503-508
    PubMedGoogle Scholar
  • 47 Davidorf F H, Havener W H, Lang J R. Macular vision following retinal detachment surgery.  Ophthalmol Surg. 1975;  6 74
    PubMedGoogle Scholar
  • 48 Machemer R. Experimental retinal detachment in the owl monkey. Histology of retina and pigment epithelium.  Am J Ophthalmol. 1968;  66 396
    PubMedGoogle Scholar
  • 49 Hagimura N, Iida T, Suto K et al. Persistent foveal retinal detachment after successful rhegmatogenous retinal detachment surgery.  Am J Ophthalmol. 2002;  133 516-520
    CrossrefPubMedGoogle Scholar
  • 50 Hassan T S, Sarrafizadeh R, Ruby A J et al. The effect of duration of macular detachment on results after the scleral buckle repair of primary, macula-off retinal detachments.  Ophthalmology. 2002;  109 146-152
    CrossrefPubMedGoogle Scholar
  • 51 Kusaka S, Toshino A, Ohashi Y et al. Long-term visual recovery after scleral buckling for macular-off retinal detachments.  Jpn J Ophthalmol. 1998;  42 218-222
    CrossrefPubMedGoogle Scholar
  • 52 Feltgen N, Schmidt D, Hansen L. Arterielle retinale Verschlüsse.  Ophthalmologe. 2003;  100 651-665
    CrossrefPubMedGoogle Scholar
  • 53 Hayreh S S, Zimmerman M B. Central retinal artery occlusion: visual outcome.  Am J Ophthalmol. 2005;  140 376-391
    PubMedGoogle Scholar
  • 54 Sharma S, Naqvi A, Sharma S M et al. Transthoracic echocardiographic findings in patients with acute central retinal artery obstruction. A retrospective review. Retinal Emboli of Cardiac Origin Group.  Arch Ophthalmol. 1996;  114 1189-1192
    PubMedGoogle Scholar
  • 55 Kuhli-Hattenbach C, Scharrer I, Lüchtenberg M et al. Selective thrombophilia screening of patients with nonarteritic anterior ischemic optic neuropathy.  Graefes Arch Clin Exp Ophthalmol. 2009;  247 485-490
    CrossrefPubMedGoogle Scholar
  • 56 Nelson M E, Talbot J F, Preston F E. Recurrent multiple-branch retinal arteriolar occlusions in a patient with protein C deficiency.  Graefes Arch Clin Exp Ophthalmol. 1989;  227 443-447
    CrossrefPubMedGoogle Scholar
  • 57 Mueller A J, Neubauer A S, Schaller U et al. Evaluation of minimally invasive therapies and rationale for a prospective randomized trial to evaluate selective intra-arterial lysis for clinically complete central retinal artery occlusion.  Arch Ophthalmol. 2003;  121 1377-1381
    CrossrefPubMedGoogle Scholar
  • 58 The GUSTO Investigators . An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction.  N Engl J Med. 1993;  329 673-682
    CrossrefPubMedGoogle Scholar
  • 59 The GUSTO angiographic investigators . The effects of tissue plasminogen activator, streptokinase, or both on coronary-artery patency, ventricular function, and survival after acute myocardial infarction.  N Engl J Med. 1993;  329 1615-1622
    CrossrefPubMedGoogle Scholar
  • 60 Konstantinides S, Geibel A, Heusel G et al. Heparin plus alteplase compared with heparin alone in patients with submassive pulmonary embolism.  N Engl J Med. 2002;  347 1143-1150
    CrossrefPubMedGoogle Scholar
  • 61 Brott T G, Haley Jr. E C, Levy D E. Urgent therapy for stroke. I. Pilot study of tissue plasminogen activator administered within 90 minutes.  Stroke. 1992;  23 632-640
    PubMedGoogle Scholar
  • 62 Haley Jr. E C, Levy D E, Brott T G. Urgent therapy for stroke. II. Pilot study of tissue plasminogen activator administered 91–180 minutes from onset.  Stroke. 1992;  23 641-645
    PubMedGoogle Scholar
  • 63 Kolbel T, Lindh M, Holst J et al. Extensive acute deep vein thrombosis of the iliocaval segment: midterm results of thrombolysis and stent placement.  J Vasc Interv Radiol. 2007;  18 243-250
    CrossrefPubMedGoogle Scholar
  • 64 Ouriel K, Veith F J, Sasahara A A. Comparison of recombinant urokinase with vascular surgery as initial treatment for acute arterial occlusion of the legs. Thrombolysis or Peripheral Arterial Surgery (TOPAS) Investigators.  N Engl J Med. 1998;  338 1105-1111
    CrossrefPubMedGoogle Scholar
  • 65 Bertram B, Wolf S, Fisches H et al. Lysebehandlung bei retinalen Arterienverschlüssen mit Plasminogen-Aktivator.  Klin Mbl Augenheilk. 1991;  198 295-300
    PubMedGoogle Scholar
  • 66 Feltgen N, Neubauer A, Jurklies B et al. Multicenter study of the European Assessment Group for Lysis in the Eye (EAGLE) for the treatment of central retinal artery occlusion: design issues and implications. EAGLE Study report no.1.  Graefes Arch Clin Exp Ophthalmol. 2006;  244 950-956
    CrossrefPubMedGoogle Scholar
  • 67 Hattenbach L O, Kuhli-Hattenbach C, Scharrer I et al. Intravenous thrombolysis with low-dose recombinant tissue plasminogen activator in central retinal artery occlusion.  Am J Ophthalmol. 2008;  146 700-706
    CrossrefPubMedGoogle Scholar
  • 68 Biousse V. Thrombolysis for acute central retinal artery occlusion: is it time?.  Am J Ophthalmol. 2008;  146 631-634
    CrossrefPubMedGoogle Scholar
  • 69 Hayreh S S, Zimmermann M B, Kimura A et al. Central retinal artery occlusion. Retinal survival time.  Exp Eye Res. 2004;  78 723-736
    CrossrefPubMedGoogle Scholar
  • 70 Lang G E. Zentralvenenverschlüsse.  Klin Monatsbl Augenheilkd. 2007;  224 R95-R109
    Article in Thieme ConnectPubMedGoogle Scholar
  • 71 Kuhli C, Hattenbach L O, Scharrer I et al. High prevalence of resistance to APC in young patients with retinal vein occlusion.  Graefes Arch Clin Exp Ophthalmol. 2002;  240 163-168
    CrossrefPubMedGoogle Scholar
  • 72 Kuhli C, Scharrer I, Koch F et al. Factor XII deficiency: A thrombophilic risk factor for retinal vein occlusion.  Am J Ophthalmol. 2004;  137 459-464
    CrossrefPubMedGoogle Scholar
  • 73 Hayreh S S. Classification of central retinal vein occlusion.  Am Ac Ophthalmol. 1983;  90 458-474
    PubMedGoogle Scholar
  • 74 Hayreh S S, Rojas P, Podhajsky P et al. Ocular neovascularization with retinal vascular occlusion-III. Incidence of ocular neovascularization with retinal vein occlusion.  Ophthalmology. 1983;  90 488-506
    PubMedGoogle Scholar
  • 75 Quinlan P M, Elman M J, Bhatt A K et al. The natural course of central retinal vein occlusion.  Am J Ophthalmol. 1990;  110 118-123
    PubMedGoogle Scholar
  • 76 Chen H C, Wiek J, Gupta A et al. Effect of isovolaemic haemodilution on visual outcome in branch retinal vein occlusion.  Br J Ophthalmol. 1998;  82 162-167
    CrossrefPubMedGoogle Scholar
  • 77 Hansen L L, Wiek J, Schade M et al. The effect and compatibility of isovolaemic haemodilution in the treatment of ischaemic and non-ischaemic central retinal vein occlusion.  Ophthalmologica. 1998;  199 90-99
    PubMedGoogle Scholar
  • 78 Hansen L L, Wiek J, Wiederholt M. A randomised prospective study of treatment of non-ischaemic central retinal vein occlusion by isovolaemic haemodilution.  Brit J Ophthalmol. 1989;  73 895-899
    CrossrefPubMedGoogle Scholar
  • 79 Hattenbach L O, Wellermann G, Steinkamp G W K et al. Visual outcome after treatment with low dose rt-PA or hemodilution in ischemic central retinal vein occlusion.  Ophthalmologica. 1999;  213 360-366
    CrossrefPubMedGoogle Scholar
  • 80 Opremcak E M, Rehmar A J, Ridenour C D et al. Radial optic neurotomy for CRVO: 117 consecutive cases.  Retina. 2006;  26 297-305
    CrossrefPubMedGoogle Scholar
  • 81 Hasselbach H C, Ruefer F, Feltgen N et al. Treatment of central retinal vein occlusion by radial optic neurotomy in 107 cases.  Graefes Arch Clin Exp Ophthalmol. 2007;  245 1145-1156
    CrossrefPubMedGoogle Scholar
  • 82 Weis E, Gan K D, Hinz B J et al. A retrospective cohort study of radial optic neurotomy for severe central retinal vein occlusions.  Can J Ophthalmol. 2008;  43 73-78
    CrossrefPubMedGoogle Scholar
  • 83 Feltgen N, Herrmann J, Sammain A et al. Arteriovenous dissection after isovolaemic haemodilution in branch retinal vein occlusion: a nonrandomised prospective study.  Graefes Arch Clin Exp Ophthalmol. 2006;  244 829-835
    PubMedGoogle Scholar
  • 84 Iturralde D, Spaide R F, Meyerle C B et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study.  Retina. 2006;  26 279-284
    CrossrefPubMedGoogle Scholar
  • 85 Kreutzer T C, Alge C S, Wolf A H et al. Intravitreal bevacizumab for the treatment of macular oedema secondary to branch retinal vein occlusion.  Br J Ophthalmol. 2008;  92 351-355
    CrossrefPubMedGoogle Scholar
  • 86 Priglinger S G, Wolf A H, Kreutzer T C et al. Intravitreal bevacizumab injections for treatment of central retinal vein occlusion: six-month results of a prospective trial.  Retina. 2007;  27 1004-1012
    CrossrefPubMedGoogle Scholar
  • 87 Stahl A, Agostini H, Hansen L L et al. Bevacizumab in retinal vein occlusion – results of a prospective case series.  Graefes Arch Clin Exp Ophthalmol. 2007;  245 1429-1436
    CrossrefPubMedGoogle Scholar
  • 88 Ferrara D C, Koizumi H, Spaide R F. Early bevacizumab treatment of central retinal vein occlusion.  Am J Ophthalmol. 2007;  144 864-871
    CrossrefPubMedGoogle Scholar
  • 89 Jonas J B, Kreissig I, Degenring R. Intravitreal triamcinolone acetonide for treatment of intraocular proliferative, exudative, and neovascular diseases.  Prog Retin Eye Res. 2005;  24 587-611
    CrossrefPubMedGoogle Scholar

Prof. Dr. med. Hans Hoerauf

Augenklinik
Universitätsmedizin Göttingen

Robert-Koch-Straße 40

37075 Göttingen

Email: hanshoerauf@yahoo.com

    www.thieme-connect.de/DOI/DOI?10.1055/s-0029-1185822
>